Neurotoxicology is a relatively young discipline that has undergone significant growth during the last 25 years. During the late 1970s and 1980s, numerous national and international conferences and meetings were devoted to the topic of neurotoxicology, the formation of societies or specialty sections related to neurotoxicology, and the establishment of two independent peer-reviewed journals devoted to neurotoxicology. This decade was also associated with a rapid increase in our knowledge of chemical effects on the structure and function of the nervous system. During the 1990s, regulatory agencies such as the U.S. Environmental Protection Agency accepted neurotoxicology as a crucial end point and neurotoxicity testing and risk assessment guidelines were published. Neurotoxicology has also been accepted at the international level as evidenced by environmental criteria documents published by the International Programme on Chemical Safety and testing guidelines by the Organization of Economic Cooperation and Development. In recent years, there has been increased concern that the etiology of some neurodegenerative diseases may be associated with exposure to neurotoxic agents and that subpopulations of humans such as children and the elderly may be differentially sensitive to neurotoxic exposure. In the future, mechanistic information derived from basic research will be used in the identification and characterization of chemicals with neurotoxic potential. 
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Tilson (2) also notes that research is needed to clarify the role that environmental factors appear to play a role in the etiology of some neurodegenerative diseases. For example, several neurodegenerative diseases such as amyotrophic lateral sclerosis-Parkinsonism-dementia complex, neurolathyrisms, and mussel poisoning have been associated with excitatory amino acid-induced neuronal damage (19) , whereas exposure to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine has been shown to produce a Parkinson's-like syndrome in humans and experimental animals (20, 21) . More recent research has implicated young-onset Parkinson's disease (22) and extrapyramidal disorders (23) to exposure to pesticide agents. Clearly, this is an important area for future research, since some neurodegenerative diseases appear to have a genetic component that could be affected by environmental influences.
It is now widely recognized that human environmental exposure to chemicals is not associated with a single chemical (24) .
Because exposure may occur either simultaneously or sequentially to large numbers of agents from different sources or by differing routes, there are few commonly accepted approaches for the risk assessment of mixtures. Tilson (2) noted the need to determine if the neurotoxicity of individual chemicals differs quantitatively and qualitatively from that of the same chemicals in a mixture. Some experiments with mixtures of neurotoxic agents suggest that they act in an additive or less-than-additive fashion. For example, Rebert et al. (25) exposed rats by inhalation to pairs of solvents that cause hearing damage when given individually. Hearing loss was evaluated using electrophysiological techniques and the effects were predicted by a linear dose-additive model, indicating an additive rather than a synergistic or antagonistic interaction. Kodavanti and Ward (26) studied the interactive effects of several polychlorinated biphenyl (PCB) congeners in vitro. Their results also suggest that the biological effects of mixtures of PCB congeners fit a dose-additive model. It is clear that understanding the toxicology of chemicals in mixtures is a complex problem, and better mechanistic information will be needed to predict synergistic effects.
Tilson (2) also pointed out that neurotoxicology risk assessment would grow during the 1990s. During this decade, significant progress has been made to develop and validate methods to screen and characterize all classes of neurotoxicants, to better understand structure-activity relationships for several dasses of chemicals, to improve extrapolation from animal data to human risk, and to characterize neurotoxic mechanisms for some chemicals. This progress s indicated by the FUTURE DIRECTIONS IN NEUROTOXICOLOGY publication of the U.S. EPA neurotoxicology risk assessment guidelines (27) Much future research will continue to focus on the problems of children and infants. For example, there is a need to elucidate the functional modalities that may be altered following developmental exposure and to develop improved animal models to examine the neurotoxic effects of exposure during the premating and early postmating periods and in neonates. Researchers need to better understand the relationship between maternal and developmental neurotoxicity and to provide information concerning the concept of a threshold for certain types of developmental neurotoxicological effects.
The toxicological assessment of chemical mixtures remains a very complex problem. Research is needed to address mechanisms of synergistic or antagonistic response of chemicals given together via the same or differing exposure media. Additional research is needed to improve animal models for examining the effects of agents given by various routes of exposure and determine the effects of recurrent exposures over prolonged periods of time. Such research will aid in the evaluation and interpretation of data obtained from real-world environmental exposures and will lead to methods to assess risk more precisely.
Finally, research is needed to advance the application of more quantitative models in neurotoxicology risk assessment. Approaches for improved mathematical modeling of neurotoxic effects need to be developed if neurotoxicological data are to be used routinely in risk assessment.
